AI Governance Frameworks

Health-system AI governance is usually built on a small set of external frameworks: NIST AI RMF for structure, CHAI for health assurance, Joint Commission for responsible use, and domain guidance such as the ACR practice parameter.

Few health systems write an AI governance program from scratch. They assemble it from a handful of published frameworks and adapt the result to local structure, risk tolerance, and the tools they actually run. Knowing what each framework is for keeps a program from either duplicating effort or leaving gaps.

AI Governance in Healthcare

AI governance in healthcare is how an organization decides which AI tools enter care, on what evidence, under whose ownership, and with what monitoring. This is the practical structure most health systems build.

1 view

Clinical AI Governance Starts Below the Application Layer

Clinical AI governance is usually discussed at the model, vendor, and workflow levels. But hospitals also need to govern the infrastructure below the application layer: data locality, uptime, access, logs, monitoring, recovery, and system change.

16 views

Clinical AI Governance Framework

A clinical AI governance framework gives hospitals a way to review, deploy, monitor, and retire AI tools with clear accountability. The goal is not bureaucracy for its own sake, but safer decisions around risk, evidence, privacy, workflow, vendor management, and ongoing oversight.

27 views

About AI Governance Frameworks

The Frameworks in Common Use

  • NIST AI Risk Management Framework. A domain-neutral structure organized around govern, map, measure, and manage. Most healthcare programs use it as the skeleton and layer clinical specifics on top.
  • Coalition for Health AI (CHAI). Health-specific assurance practices, common terminology, and the idea of independent assurance labs and model reporting for clinical AI.
  • Joint Commission guidance on responsible use of AI in healthcare. Expectations around policies, governance structure, data use, validation, monitoring, transparency, and patient safety for accredited organizations.
  • ACR imaging AI practice parameter and Assess-AI. Radiology-specific guidance on acceptance testing, ongoing performance monitoring, and structured real-world data collection.
  • FDA guidance on AI-enabled medical devices and predetermined change control plans. Defines what makes a tool a regulated device, how it is cleared, and how anticipated model changes are handled.
  • AHRQ and specialty-society statements. Evidence standards and use-case-specific cautions that inform risk tiering and validation depth.

How They Fit Together

A workable pattern: use NIST AI RMF for the governance structure and risk process, CHAI for health-specific assurance language and model documentation, Joint Commission expectations as the compliance backstop, and domain guidance such as the ACR parameter for the validation and monitoring detail in a given clinical area. FDA guidance governs the subset of tools that are regulated devices.

Turning a Framework Into a Program

  1. Adopt one framework as the structural base and name it in policy.
  2. Define local risk tiers and the review depth each tier requires.
  3. Map each framework expectation to an owner and an artifact, such as an inventory entry, a validation report, or a monitoring dashboard.
  4. Pilot the process on two or three real tools before scaling.
  5. Review the program annually against framework updates.

Related AI Medicine Now Topics